IN2012DN06061A - - Google Patents

Download PDF

Info

Publication number
IN2012DN06061A
IN2012DN06061A IN6061DEN2012A IN2012DN06061A IN 2012DN06061 A IN2012DN06061 A IN 2012DN06061A IN 6061DEN2012 A IN6061DEN2012 A IN 6061DEN2012A IN 2012DN06061 A IN2012DN06061 A IN 2012DN06061A
Authority
IN
India
Prior art keywords
pyrazol
thiazole
disorders
inhibitors
diseases
Prior art date
Application number
Other languages
English (en)
Inventor
Nicole Cathleen Goodwin
David Brent Rawlins
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of IN2012DN06061A publication Critical patent/IN2012DN06061A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN6061DEN2012 2010-01-22 2011-01-21 IN2012DN06061A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29739710P 2010-01-22 2010-01-22
PCT/US2011/021970 WO2011091204A1 (en) 2010-01-22 2011-01-21 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye

Publications (1)

Publication Number Publication Date
IN2012DN06061A true IN2012DN06061A (enExample) 2015-09-18

Family

ID=43760212

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6061DEN2012 IN2012DN06061A (enExample) 2010-01-22 2011-01-21

Country Status (8)

Country Link
US (1) US20130059896A1 (enExample)
EP (1) EP2525794A1 (enExample)
JP (1) JP2013518048A (enExample)
CN (1) CN102711758A (enExample)
AU (1) AU2011207280A1 (enExample)
CA (1) CA2786730A1 (enExample)
IN (1) IN2012DN06061A (enExample)
WO (1) WO2011091204A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2012170931A2 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
EP3515909A1 (en) 2016-09-23 2019-07-31 Cellipse Lim kinase inhibitors, pharmaceutical composition and method of use in limk-mediated diseases
CN115197166B (zh) * 2022-07-11 2024-07-02 安徽英瑞骐生物科技有限公司 一种4-甲基-2-肼基苯并噻唑的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
EP1020447A4 (en) * 1997-09-11 2000-11-15 Nissan Chemical Ind Ltd PYRAZOLE-BASED COMPOUNDS AND PLANT DISEASE CONTROL AGENT
WO2002099083A2 (en) 2001-06-05 2002-12-12 Exelixis, Inc. Gfats as modifiers of the p53 pathway and methods of use
US20050008643A1 (en) 2001-06-27 2005-01-13 Ora Bernard Diagnostic methods and agents
WO2004047868A1 (ja) 2002-11-27 2004-06-10 Santen Pharmaceutical Co., Ltd. Limキナーゼ阻害作用を有する化合物を有効成分とする緑内障治療剤
TWI336257B (en) 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
AU2008236679B2 (en) 2007-04-03 2013-11-28 Fmc Corporation Substituted benzene fungicides
ES2557931T3 (es) 2007-08-08 2016-01-29 Lexicon Pharmaceuticals, Inc. (7H-Pirrolo[2,3-d]pirimidin-4-il)-piperazinas como inhibidores de cinasas para el tratamiento de cáncer e inflamación
EP2297153B1 (en) 2008-04-21 2015-05-27 Lexicon Pharmaceuticals, Inc. Limk2 inhibitors, compositions comprising them, and methods of their use

Also Published As

Publication number Publication date
AU2011207280A1 (en) 2012-07-19
WO2011091204A1 (en) 2011-07-28
CA2786730A1 (en) 2011-07-28
CN102711758A (zh) 2012-10-03
US20130059896A1 (en) 2013-03-07
EP2525794A1 (en) 2012-11-28
JP2013518048A (ja) 2013-05-20

Similar Documents

Publication Publication Date Title
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
UA116774C2 (uk) Інгібітори серин/треонінкінази
PH12014500468A1 (en) Heterocyclic compounds and uses thereof
WO2014028591A3 (en) N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
HK1198443A1 (en) Heterocyclic compounds and uses thereof
MX2015012431A (es) Pirrol amida como inhibidores.
WO2014031928A3 (en) Heterocyclic modulators of hif activity for treatment of disease
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
EA023222B8 (ru) Пиразолилхиноксалиновые ингибиторы киназы
MX2014012695A (es) Derivados de isoindolona.
HK1207069A1 (en) Heterocyclic compounds and uses thereof
WO2014179564A8 (en) Thiazolopyrrolidine inhibitors of ror-gamma
AU2012214029A8 (en) Rorgammat inhibitors
MX353806B (es) Quinolinas como moduladores de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr).
MX370906B (es) Inhibidores de serina/treonina cinasa.
WO2012013282A8 (en) Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k
WO2014031933A3 (en) Heterocyclic modulators of hif activity for treatment of disease
WO2012048129A3 (en) Inhibitors of polo-like kinase
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
LT3335709T (lt) Gama-hidroksibutirato kompozicijos ir jų naudojimas sutrikimams gydyti
WO2014031936A3 (en) Heterocyclic modulators of hif activity for treatment of disease
MX337849B (es) Composiciones y metodos para inhibicion de la via jak.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IN2015DN01151A (enExample)